Statins are associated with reduced use of steroids in inflammatory bowel disease: A retrospective cohort study*

Adverse effects of biologics used for treating IBD

(2010) Andreas Stallmach et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

The pharmacoeconomics of biologic therapy for IBD

(2010) Russell D. Cohen   Nature Reviews Gastroenterology & Hepatology

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk of Arterial Thrombotic Events in Inflammatory Bowel Disease

(2009) Christina Ha et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Utilization of lipid lowering medications among adults in the United States 1999–2006

(2009) Mingfang Li et al.   ATHEROSCLEROSIS

Effectiveness of rosuvastatin compared to other statins for the prevention of cardiovascular events—a cohort study in 395 039 patients from clinical practice

(2009) Stephen P. Motsko et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Atorvastatin Reduces Plasma Levels of Chemokine (CXCL10) in Patients with Crohn's Disease

(2009) Olof Grip et al.   PLoS One

Colectomy and the Incidence of Postsurgical Complications Among Ulcerative Colitis Patients With Private Health Insurance in the United States

(2008) Edward V. Loftus et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Incidence and Prevalence of Inflammatory Bowel Disease in a Northern California Managed Care Organization, 1996-2002

(2008) Lisa J. Herrinton et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease

(2008) O Grip et al.   BRITISH JOURNAL OF PHARMACOLOGY

Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults

(2008) Michael D. Kappelman et al.   GASTROENTEROLOGY